1-Amino-2-methyl-propan-2-ol hydrochloride, 95.0%, 25g

5-Vinylisophthalic acid, 97% mix TBC as stabilizer, 10g

4,4-Difluoropyrrolidine-3-carboxylic acid hydrochloride, 98%, 500mg

1-dodecyl-3-methylimidazolium chloride, 97%, 100g

Nicotinic acid, 95.0%, 25g

N-(Pyridin-4-yl)acetamide, 95.0%, 5g

1-Ethylpiperidine>98.0%(GC)(T)25mL

Ethyl 4-bromo-3-ethyl-1-methyl-1H-pyrazole-5-carboxylate, 95+%, 2g

(R)-N-(2-Propynyl)-2,3-dihydroinden-1-amine, 95.0%, 250mg

1-[3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[(1E)-2-(phenylsulfonyl)ethenyl]-1H-indol-1-yl]ethanone, 98%, 10g

5-((3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)-5H-dibenzo[b,f]azepine, 97%, 100mg

4'-bromo-3-(4-chlorophenyl)-2'-fluoropropiophenone, 97.0%, 1g

2,6-dimethylimidazo[1,2-a]pyridine-3-carboxylic acid, 95.0%, 1g